Decrease in hepatic cytochrome P450 after interleukin-2 immunotherapy

This publication has 19 references indexed in Scilit:

• Biology of Natural Killer Cells
  Published by Elsevier ,2008
• P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature
  Pharmacogenetics, 1996
• The interleukin-2 receptor down-regulates the expression of cytochrome P450 in cultured rat hepatocytes
  Gastroenterology, 1995
• Genistein, a Tyrosine Kinase Inhibitor, Decreased the Affinity of p56lck to -Chain of Interleukin-2 Receptor in Human Natural Killer (NK)-Rich Cells and Decreased NK-Mediated Cytotoxicity
  Experimental Biology and Medicine, 1994
• Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T-cell proliferation
  Nature, 1994
• The IL-2/IL-2 receptor system: a target for rational immune intervention
  Immunology Today, 1993
• A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part I: Clinical aspects
  British Journal of Cancer, 1992
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987
• High-Dose Recombinant Interleukin 2 in the Treatment of Patients With Disseminated Cancer
  JAMA, 1986
• Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells.
  The Journal of Experimental Medicine, 1983